Trial Profile
ONO-2745 phase II study in patients undergoing a surgery under general anesthesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications General anaesthesia
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 04 Apr 2014 New trial record